Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CP-547632 is an orally available and potent, ATP-competitive dual inhibitor of VEGFR-2 and FGF kinase F with IC50s of 11 nM and 9 nM, respectively. CP-547632 is selective, with higher selectivity for VEGFR2 and bFGF than for EGFR, PDGFRβ and related tyrosine kinases (TKs). PDGFRβ and related tyrosine kinases (TKs) CP-547632 has antitumour activity.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 7,000 | |||
2 mg | 在庫あり | ¥ 10,000 | |||
5 mg | 在庫あり | ¥ 16,000 | |||
10 mg | 在庫あり | ¥ 22,500 | |||
25 mg | 在庫あり | ¥ 41,000 | |||
50 mg | 在庫あり | ¥ 58,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 18,500 |
ターゲット&IC50 | VEGFR2:11 nM, FGFR:9 nM |
分子量 | 532.4 |
分子式 | C20H24BrF2N5O3S |
CAS No. | 252003-65-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 90.0 mg/mL (169.0 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CP-547632 252003-65-9 Angiogenesis Tyrosine Kinase/Adaptors FGFR VEGFR PDGFR BTK CP547632 CP 547632 Inhibitor inhibitor inhibit